1. |
Lim DJ, Baek KH, Lee YS, et al. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma [J].Thyroid, 2007, 17(9): 883888.
|
2. |
马峻峰, 唐波, 李铁汉, 等. 促甲状腺激素抑制疗法在分化型甲状腺癌治疗中的作用 [J]. 中国普外基础与临床杂志, 2009, 16(5): 348350.
|
3. |
Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyrroid gland: the GustaveRoussy Institute experience [J]. Cancer, 1998, 83(3): 553559.
|
4. |
Park YJ, Kim YA, Lee YJ, et al. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings [J]. Head Neck, 2010, 32(1): 3845.
|
5. |
季正标, 张晖, 俞清, 等. 灰阶及彩色多普勒血流成像在甲状腺癌诊断中的应用 [J]. 中国医学影像技术, 2002, 18(7): 554556.
|
6. |
陈皓. 结节性甲状腺肿合并乳头状微小癌的彩色超声诊断分析 [J]. 当代医学, 2009, 15(6): 135.
|
7. |
赵艳侠, 杜红丽. 钙化在甲状腺结节良恶性鉴别诊断中的价值200例分析 [J]. 中国误诊学杂志, 2009, 9(31): 76837684.
|
8. |
周文斌, 周冬仙, 麦沛成, 等. 结节性甲状腺肿并存甲状腺微小癌: 54例报告 [J]. 中国现代医学杂志, 2009, 19(22): 34703472.
|
9. |
盖宝东, 郑泽霖, 张德恒, 等. 169例结节性甲状腺肿与甲状腺癌并存的诊治体会 [J]. 中国普外基础与临床杂志, 2004, 11(6): 496497.
|
10. |
Gurleyik E, Coskun O, Aslaner A. Clinical importance of solitary solid nodule of the thyroid in endemic goiter region [J]. Indian J Med Sci, 2005, 59(9): 388395.
|
11. |
武阿丽, 许长起, 任玉波. 结节性甲状腺肿合并甲状腺乳头状微小癌18例病理分析 [J]. 肿瘤基础与临床, 2009, 22(3): 259260.
|
12. |
Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients [J]. Eur J Surg Oncol, 2006, 32(10): 11441148.
|
13. |
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma. V. 1. 2010 [EB/OL]. http://www.nccn.org/professionals/physcian_gls/PDF/thyroid.
|
14. |
Besic N, Pilko G, Petric R, et al. Papillary thyroid microcarcinoma: prognostic factors and treatment [J]. J Surg Oncol, 2008, 97(3): 221225.
|
15. |
Giordano D, Gradoni P, Oretti G, et al. Treatment and prognostic factors of papillary thyroid microcarcinoma [J]. Clin Otolaryngol, 2010, 35(2): 118124.
|